Non-Hodgkin’s lymphoma (NHL)
$3,600 guaranteed award | $7,200 maximum award
Get notified when openHelp with healthcare costs for non-Hodgkin's lymphoma
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for non-Hodgkin's lymphoma, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have government-insured coverage that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Absorica (Isotretinoin)
- Acitretin (Acitretin)
- Actimmune (Interferon Gamma-1B)
- Adcetris (Brentuximab Vedotin)
- Adriamycin (Doxorubicin Hydrochloride)
- ALBUTEIN (Albumin Human)
- Alkeran (Melphalan)
- Amnesteem (Isotretinoin)
- Arsenic Trioxide (Arsenic Trioxide)
- Beleodaq (Belinostat)
- Bendamustine (Bendamustine Hcl)
- Bexarotene (Bexarotene)
- Bicnu (Carmustine)
- Bortezomib (Bortezomib)
- Boruzu (Bortezomib)
- Breyanzi (Lisocabtagene Maraleucel)
- Brukinsa (Zanubrutinib)
- Calquence (Acalabrutinib)
- Campath (Alemtuzumab)
- Carboplatin (Carboplatin)
- Carmustine (Carmustine)
- Cisplatin (Cisplatin)
- Claravis (Isotretinoin)
- Copiktra (Duvelisib)
- Cyclophosphamide (Cyclophosphamide)
- Cyclosporine (Cyclosporine)
- Cyclosporine Modified (Cyclosporine)
- Cytarabine (Cytarabine)
- Depo-Medrol (Methylprednisolone Acetate)
- Dermacinrx Lidocan (Lidocaine)
- Dermacinrx Lidorex (Lidocaine Hydrochloride)
- Dexabliss (Dexamethasone)
- Dexamethasone (Dexamethasone)
- Dexamethasone Acetate Anhydrous (Dexamethasone Acetate)
- Dexamethasone Intensol (Dexamethasone)
- Dexamethasone Sodium Phosphate (Dexamethasone Sodium Phosphate)
- Dexamethasone Sod Phos-Water (Dexamethasone Sodium Phosphate)
- Doxorubicin Hcl (Doxorubicin Hydrochloride)
- Epkinly (Epcoritamab-Bysp)
- Etopophos (Etoposide Phosphate)
- Etoposide (Etoposide)
- Fludarabine Phosphate (Fludarabine Phosphate)
- Folotyn (Pralatrexate)
- Frindovyx (Cyclophosphamide)
- Gazyva (Obinutuzumab)
- Gemcitabine Hcl (Gemcitabine)
- Gengraf (Cyclosporine)
- Ifex (Ifosfamide)
- Ifosfamide (Ifosfamide)
- Imbruvica (Ibrutinib)
- Imiquimod (Imiquimod)
- Isotretinoin (Isotretinoin)
- Istodax (Romidepsin)
- Keytruda (Pembrolizumab)
- Kymriah (Tisagenlecleucel)
- Lenalidomide (Lenalidomide)
- Leucovorin Calcium (Leucovorin Calcium)
- Leukeran (Chlorambucil)
- Lidocaine (Lidocaine)
- Lidocaine Hcl (Lidocaine Hydrochloride)
- Lidocan III (Lidocaine)
- Lidocan IV (Lidocaine)
- Lidocan V (Lidocaine)
- Lunsumio (Mosunetuzumab-Axgb)
- MAS CARE-PAK DEXAMETHASONE (Dexamethasone Sodium Phosphate)
- Matulane (Procarbazine Hydrochloride)
- Medrol (Methylprednisolone)
- Melphalan HCl (Melphalan Hydrochloride)
- Mesna (Mesna)
- Mesnex (Mesna)
- Methotrexate-Nacl (Methotrexate Sodium)
- Methotrexate Sodium (Methotrexate Sodium)
- Methylprednisolone (Methylprednisolone)
- Methylprednisolone Acetate (Methylprednisolone Acetate)
- Methylprednisolone Sodium Succinate (Methylprednisolone Sodium Succinate)
- Millipred DP (Prednisolone)
- Mitoxantrone HCl (Mitoxantrone Hydrochloride)
- Monjuvi (Tafasitamab-Cxix)
- Nelarabine (Nelarabine)
- Neoral (Cyclosporine)
- Nipent (Pentostatin)
- Oncaspar (Pegaspargase)
- Opdivo (Nivolumab)
- OPDIVO QVANTIG (Nivolumab-Hyaluronidase-Nvhy)
- Oxaliplatin (Oxaliplatin)
- Paraplatin (Carboplatin)
- Pegasys (Peginterferon Alfa-2A)
- Polivy (Polatuzumab Vedotin-Piiq)
- Poteligeo (Mogamulizumab-Kpkc)
- Pralatrexate (Pralatrexate)
- Prednisolone (Prednisolone)
- Prednisolone Sodium Phosphate (Prednisolone Sodium Phosphate)
- Prednisolone Sodium Phosphate Odt (Prednisolone Sodium Phosphate)
- Prednisone (Prednisone)
- Prednisone Intensol (Prednisone)
- Retrovir (Zidovudine)
- Revlimid (Lenalidomide)
- Riabni (Rituximab-Arrx)
- Rituxan (Rituximab)
- Romidepsin (Romidepsin)
- Ruxience (Rituximab-Pvvr)
- Rylaze (Asparaginase Erwinia-Rywn)
- Sandimmune (Cyclosporine)
- Solu-Medrol (Methylprednisolone Sodium Succinate)
- Targretin (Bexarotene)
- Tazarotene (Tazarotene)
- Tazorac (Tazarotene)
- Tazverik (Tazemetostat)
- Tecartus (Brexucabtagene Autoleucel)
- Temozolomide (Temozolomide)
- Thalomid (Thalidomide)
- Treanda (Bendamustine)
- Trisenox (Arsenic Trioxide)
- Truxima (Rituximab-Abbs)
- Valchlor (Mechlorethamine Hydrochloride)
- Velcade (Bortezomib)
- Venclexta (Venetoclax)
- Vincristine Sulfate (Vincristine Sulfate)
- Vykoura (Leucovorin Calcium)
- Xalkori (Crizotinib)
- Xpovio (Selinexor)
- Xylocaine (Lidocaine Hydrochloride)
- Yescarta (Axicabtagene Ciloleucel)
- Zenatane (Isotretinoin)
- Zevalin (Ibritumomab Tiuxetan / Yttrium Y-90)
- Zidovudine (Zidovudine)
- Zolinza (Vorinostat)
- Zydelig (Idelalisib)
- Zynlonta (Loncastuximab Tesirine-Lpyl)
About the disease
Non-Hodgkin’s lymphoma (also called non-Hodgkin lymphoma and NHL) is a type of blood cancer that originates in the lymphatic system. NHL affects the circulatory system. Subtypes include: chronic lymphocytic leukemia or small lymphocytic lymphoma, follicular lymphoma, gastric MALT lymphoma, nongastric MALT lymphoma, nodal marginal zone lymphoma, splenic marginal zone lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, Burkitt lymphoma, lymphoblastic lymphoma, AIDS-related B-cell lymphomas, hairy cell leukemia, primary cutaneous B-cell lymphomas, peripheral T-cell lymphomas, mycosis fungoides or Sézary syndrome, primary cutaneous CD30+ T-cell lymphoproliferative disorders, T-cell large granular lymphocytic leukemia, adult T-cell leukemia or lymphoma, T-cell prolymphocytic leukemia, extranodal NK/T-cell lymphoma: nasal type, post-transplant lymphoproliferative disorders and Castleman’s disease.
Diagnosis codes
C82.00, C82.01, C82.02, C82.03, C82.04, C82.05, C82.06, C82.07, C82.08, C82.09, C82.10, C82.11, C82.12, C82.13, C82.14, C82.15, C82.16, C82.17,
C82.18, C82.19, C82.20, C82.21, C82.22, C82.23, C82.24, C82.25, C82.26, C82.27, C82.28, C82.29, C82.30, C82.31, C82.32, C82.33, C82.34, C82.35, C82.36, C82.37, C82.38, C82.39, C82.40, C82.41, C82.42, C82.43, C82.44, C82.45, C82.46, C82.47, C82.48, C82.49, C82.50, C82.51, C82.52, C82.53, C82.54, C82.55, C82.56, C82.57, C82.58, C82.59, C82.60, C82.61, C82.62, C82.63, C82.64, C82.65, C82.66, C82.67, C82.68, C82.69, C82.80, C82.81, C82.82, C82.83, C82.84, C82.85, C82.86, C82.87, C82.88, C82.89, C82.90, C82.91, C82.92, C82.93, C82.94, C82.95, C82.96, C82.97, C82.98, C82.99, C83.00, C83.01, C83.02, C83.03, C83.04, C83.05, C83.06, C83.07, C83.08, C83.09, C83.10, C83.11, C83.12, C83.13, C83.14, C83.15, C83.16, C83.17, C83.18, C83.19, C83.31, C83.32, C83.33, C83.34, C83.35, C83.36, C83.37, C83.38, C83.39, C83.50, C83.51, C83.52, C83.53, C83.54, C83.55, C83.56, C83.57, C83.58, C83.59, C83.70, C83.71, C83.72, C83.73, C83.74, C83.75, C83.76, C83.77, C83.78, C83.79, C83.80, C83.81, C83.82, C83.83, C83.84, C83.85, C83.86, C83.87, C83.88, C83.89, C83.90, C83.91, C83.92, C83.93, C83.94, C83.95, C83.96, C83.97, C83.98, C83.99, C84.00, C84.01, C84.02, C84.03, C84.04, C84.05, C84.06, C84.07, C84.08, C84.09, C84.10, C84.11, C84.12, C84.14, C84.15, C84.16, C84.17, C84.18, C84.19, C84.60, C84.61, C84.62, C84.63, C84.64, C84.65, C84.66, C84.67, C84.68, C84.69, C84.70, C84.71, C84.72, C84.73, C84.74, C84.75, C84.76, C84.77, C84.78, C84.79, C84.90, C84.91, C84.92, C84.93, C84.94, C84.95, C84.96, C84.97, C84.98, C84.99, C84.A0, C84.A1, C84.A2, C84.A3, C84.A4, C84.A5, C84.A6, C84.A7, C84.A8, C84.A9, C84.Z0, C84.Z1, C84.Z2, C84.Z3, C84.Z4, C84.Z5, C84.Z6, C84.Z7, C84.Z8, C84.Z9, C85.10, C85.11, C85.12, C85.13, C85.14, C85.15, C85.16, C85.17, C85.18, C85.19, C85.20, C85.21, C85.22, C85.23, C85.24, C85.25, C85.26, C85.27, C85.28, C85.29, C85.80, C85.81, C85.82, C85.83, C85.84, C85.85, C85.86, C85.87, C85.88, C85.89, C85.90, C85.91, C85.92, C85.93, C85.94, C85.95, C85.96, C85.97, C85.98, C85.99, C86.0, C86.1, C86.2, C86.3, C86.4, C86.5, C86.6, C88.0, C88.4, C91.10, C91.11, C91.12, C91.40, C91.41, C91.42, C91.50, C91.51, C91.52, C84.7A, C84.40, C84.41, C84.42, C84.43, C84.44, C84.45, C84.46, C84.47, C84.48, C84.49
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources